NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Tuesday that its second quarter revenues increased 3 percent year over year, due in part to its January acquisition of AbD Serotec.

The Hercules, Calif.-based firm brought in total revenues of $525.3 million for the three months ended June 30, compared to $$510.4 million for the second quarter of 2012. It fell short of the consensus Wall Street estimate of $532.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.